Nextgen Healthcare (NXGN) Set to Announce Earnings on Wednesday

Nextgen Healthcare (NASDAQ:NXGN) will be releasing its earnings data after the market closes on Wednesday, January 23rd. Analysts expect Nextgen Healthcare to post earnings of $0.11 per share for the quarter. Nextgen Healthcare has set its FY19 guidance at $0.70-$0.74 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Nextgen Healthcare (NASDAQ:NXGN) last announced its earnings results on Tuesday, October 30th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.05. The company had revenue of $130.30 million for the quarter, compared to analysts’ expectations of $134.55 million. Nextgen Healthcare had a return on equity of 10.23% and a net margin of 1.17%. Nextgen Healthcare’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.22 earnings per share. On average, analysts expect Nextgen Healthcare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of NASDAQ:NXGN opened at $18.26 on Monday. The company has a market cap of $1.18 billion, a P/E ratio of 32.04, a P/E/G ratio of 3.62 and a beta of 1.07. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.33 and a current ratio of 1.33. Nextgen Healthcare has a 12-month low of $12.24 and a 12-month high of $23.73.

Several brokerages recently issued reports on NXGN. Morgan Stanley raised Nextgen Healthcare from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $12.00 to $16.00 in a research report on Thursday, November 1st. Zacks Investment Research raised Nextgen Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, December 31st. Dougherty & Co raised Nextgen Healthcare from a “neutral” rating to a “buy” rating and set a $19.00 target price on the stock in a research report on Friday, January 11th. TheStreet cut Nextgen Healthcare from a “b-” rating to a “c+” rating in a research report on Wednesday, November 21st. Finally, KeyCorp cut their target price on Nextgen Healthcare from $17.00 to $16.00 and set an “underweight” rating on the stock in a research report on Wednesday, October 31st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $18.50.

COPYRIGHT VIOLATION NOTICE: “Nextgen Healthcare (NXGN) Set to Announce Earnings on Wednesday” was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.com-unik.info/2019/01/21/nextgen-healthcare-nxgn-set-to-announce-earnings-on-wednesday.html.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Recommended Story: Compound Interest

Earnings History for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit